Materials
The rapid development of materials and techniques over the past 20 years has resulted in more than half of all hip and knee replacements now lasting more than 25 years. But there’s still room for improvement as well as expertise, as projects like BioTrib – a multinational collaboration designed to lay the foundations for the creation of a new generation of joint interventions – have set out to prove. Project coordinator Professor Richard Hall explains that BioTrib aims to further enhance the life of joint interventions using advanced tribology – the science of interacting surfaces in relative motion, and how they cause friction, wear and lubrication. The project is designed to provide a platform from which scientists and researchers can pioneer the next wave of orthopaedic technology. “BioTrib is about capacity building and providing a comprehensive training programme to early stage researchers through a balanced set of PhD activities,” he says. “The shortage of STEM-based researchers within the EU is significant, especially when the demand will rise over the next decade.”
Interdisciplinary skills The BioTrib consortium brings together five universities, as well as representatives from across the supply chain, including materials and implant manufacturers, testing companies and clinical units. “They all possess the international, intersectoral, and interdisciplinary skills and experience needed to develop a successful medical engineer,” explains Hall, adding that the five universities – the University of Leeds, Uppsala University, ETH Zurich, Imperial College London and Lulea Technical University – act as the “core” of the project. As world-leaders in medical engineering and biotribology, they’re responsible for enrolling researchers on to PhD programmes that align with the overall BioTrib ambitions.
Current focus areas include everything from the use of additive manufacturing for novel bearings with new lubrication properties to the development of next- generation soft-bearings through novel electrospun matrices or unique nanocomposite polymers. One of the project’s hallmarks is its international nature, says Hall’s colleague and co-coordinator Dr Michael Bryant. “The engineering science base that supports the innovation and research process needs to reflect the global nature of the medical device business. This includes developing skills and a research culture that provides a recognition of the stakeholder needs not only nationally, but internationally and within different countries.” This objective is achieved through the recruitment of international students and a broad spectrum of global industry partners. Curiously, the project is an EU-funded initiative spearheaded in the post-Brexit world by Hall and
Medical Device Developments /
www.nsmedicaldevices.com
The challenge of testing longevity in artificial joints
The standard means of testing artificial hip and knee joints includes using devices to simulate the impact of walking. But neither Hall or Bryant believes this is adequate, and they’re attempting to improve testing procedures by putting the prosthetics through more rigorous assessments to reveal their weaknesses. One challenge in conducting these adverse loading tests is that the march of innovation in artificial joint technology can’t wait 15 or 20 years for the validation of new materials and designs in prosthetics. This is where the team at Leeds have to apply some mechanical engineering alchemy to speed up the process, but, in an interview with NS Medical Devices, Bryant says doing so with accuracy is still very much a work in progress for the entire orthopaedic research community.
“The simulators will run for a period of time that we think will replicate a wear rate typically expected in vivo, but the challenge is how we view that data,” he adds. “Hip simulation can be viewed and used to interrogate mechanisms of wear, the tribology and more recently the corrosion. One of the challenges that comes with progressing the simulation techniques are that we want to have something that’s realistic and representative of patients’ activity, but to do this exactly would require 15 or 20 years in the simulator. We streamline that by accelerating it to a certain degree – but there are still quite a lot of questions around how to do that effectively and appropriately.”
Designing a testing protocol that effectively replicates human activity is one of the goals that BioTrib will attempt to meet in the four years it has runway from EU funding. But it’s a big task, and Hall is already looking for additional investment, as well as hoping to negotiate another grant from the EU. In the meantime, Bryant his colleagues hope to shift the priority of artificial joint testing so that assessment procedures involve a holistic view of an implanted joint, including wear, tribology and corrosion – rather than just a walking test based on wear.
Bryant, both based at the University of Leeds in the north of England. The programme has been funded by the Marie Skłodowska-Curie Actions programme, which provides backing for doctoral and post-doctoral researchers under the European Commission’s Horizon 2020 research and innovation framework. Bryant says UK researchers have had to rebuild some bridges and navigate additional bureaucracy in the wake of Brexit in order to ensure collaborations of this nature can continue seamlessly. “In terms of Brexit, researchers in the EU often question whether UK institutions or industry can be bona fide partners in an EU-sponsored Horizon project,” he says. “They require continued reassurance – not having to do this would make life easier and allow us to focus on the research for the benefit of all stakeholders. Then there are the practical aspects, for instance, issues around visa requirements for different countries within the EU and the transfer of materials.”
Implant failure
Bryant points out that biotribology is not only a European concern, but a global one. Device failure remains an issue despite improvements in materials and designs over the past two decades. While total joint replacements have been a remarkable success in providing patients with pain-free lives and improved mobility, there are still a considerable number of revision procedures that take place annually due to the sheer volume of surgeries undertaken, defective implants and a rise in the number of younger patients
48.8%
Fewer joint replacement procedures performed across England, Wales and Northern Ireland in 2020, compared with 2019.
2031 National Joint Registry 119
Estimated year that it would take to clear the UK’s backlog with a 5% increase in provision from 2019.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170
